• Angelman Syndrome Collection Uses Fashion for NYC Fundraiser in April
  • Spanish Researchers Shed Light on Rare Gene Deletions That Can Cause Angelman Syndrome
  • Ovid to Add Adolescents to Phase 2 Trial of Its Angelman Syndrome Therapy
  • Ovid’s Epilepsy Candidate TAK-935/OV935 Shows Promising Results in Phase 1 Trials
  • FAST Summit & Gala Lures 1,300 to Chicago, Raises $4 Million for Angelman Syndrome Research
  • Photography Book, ‘An Ordinary Day,’ Portrays Kids with Rare Genetic Diseases
  • Ovid Seeks Adult Angelman Patients to Phase 2 Trial of Gaboxadol
  • Machine Learning Could Improve Ability to Assess Effectiveness of Brain Disease Studies
  • Patient Outcomes Need to Take Center Stage in Developing Rare Disease Treatments
  • Rare Disease Patient Groups Unite to Preserve Orphan Drug Tax Credit in US
  • Angelman Syndrome Foundation Opens Calls for Research Proposals
  • Statin Seen to Ease Seizures, Lessen Neuron Excitability in Angelman Mouse Model